Jakavi 5mg Tablet is used in the treatment of chronic idiopathic myelofibrosis and Polycythemia vera.

Jakavi 5mg Tablet is used to treat different types of cancer

Uses of Jakavi Tablet

Polycythemia vera
Chronic idiopathic myelofibrosis

Benefits of Jakavi Tablet

In Polycythemia vera

Polycythemia vera is a type of blood cancer that causes excessive production of red blood cells. This may lead to blood clot formation and lead to other serious health issues. Jakavi 5mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is an effective, yet very toxic medicine and you should discuss the risks and benefits with your doctor. Avoid drinking alcohol or smoking while having this treatment and drink plenty of water to stay hydrated.

In Chronic idiopathic myelofibrosis

Chronic idiopathic myelofibrosis is a long-term problem that causes fibrous, or scar, tissue to form in the bone marrow. The scarring means the bone marrow can't work normally and produces fewer red blood cells and usually too many white blood cells. Jakavi 5mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. You may experience some bothersome side effects. Discuss with your doctor if you have any doubts.

show less

Side effects of Jakavi Tablet

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Jakavi

Headache
Dizziness
Low blood platelets
Anemia (low number of red blood cells)

How to use Jakavi Tablet

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jakavi 5mg Tablet may be taken with or without food, but it is better to take it at a fixed time.

Safety advice

Alcohol

SAFE

Consuming alcohol with Jakavi 5mg Tablet does not cause any harmful side effects.

Pregnancy

CONSULT YOUR DOCTOR

Jakavi 5mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Jakavi 5mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Driving

UNSAFE

Jakavi 5mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.

Kidney

CAUTION

Jakavi 5mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jakavi 5mg Tablet may be needed. Please consult your doctor.
Use of Jakavi 5mg Tablet is not advised in patients with moderate to severe kidney disease.

Liver

CAUTION

Jakavi 5mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jakavi 5mg Tablet may be needed. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

No substitutes found for this medicine

Quick tips

Take it with or without food, preferably at the same time each day.
It may cause dizziness and headaches. Do not drive or do anything that requires mental focus until you know how it affects you.
Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine.
Your doctor may get regular blood tests done to monitor your blood cells, liver and kidney function, and lipid levels during treatment with this medicine.
Inform your doctor immediately if you notice any signs of infection such as fever, sore throat or rash.
Do not stop taking Jakavi 5mg Tablet without talking to your doctor first.

Fact Box

Chemical Class

Pyrrolo[2,3-d]pyrimidines Derivative

Habit Forming

Therapeutic Class

ANTI NEOPLASTICS

Action Class

Tyrosine kinase inhibitors

Patient concerns

She suffers from polycythemia Vera for 2.5 years.pIG doctor suggest bloodlet simply.Is there any treatment to cure this disease.

Dr. Aanchal Maheshwari

Ayurveda

Ayurveda hs a hope, but case has to be personally seen , body prakruti is assesed and then treatment is given

What is reason for the psoriasis?

Dr. Souvik Sardar

Dermatology

mostly idiopathic sometimes some Medicines may be responsible for its exacerbation

What is the IDIOPATHIC INTRACRANIAL HYPERTENSION.PLS DETAILED INFORMATION ABOUT IT AND TREATMENT . Any changes in life, style

Dr. Vikas Sharma

Neurology

In this disease , The pressure in brain is raised and it causes headache and sometimes loss of visionPlease get detailes eye checkup including visual fields and fundus. You will also need CSF study . Plas show to neurologistLifetsyle- Please reduce your weight if it is highGet thyroid. HbA1c and blood sugar checked. If abnormal get treated for them

User feedback

Patients taking Jakavi 5mg Tablet

Twice A Day

82%

Once A Day

18%

What are you using Jakavi Tablet for?

Chronic idiop*

100%

*Chronic idiopathic myelofibrosis

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1240.
Ruxolitinib. Greenville, North Carolina: DSM Pharmaceuticals, Inc.; 2011. [Accessed 24 Jan. 2019] (online) Available from:
Ruxolitinib. Wilmington, Delaware: Incyte Corporation; 2011 [revised Dec. 2014]. [Accessed 27 Mar. 2019] (online) Available from:
Ruxolitinib. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd; 2012 [revised 22 May 2018]. [Accessed 27Mar. 2019] (online) Available from:

Marketer details

Name: Novartis India Ltd

Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India

Country of origin: Switzerland
Expires on or after: February, 2025

A licensed vendor partner from your nearest location will deliver Jakavi 5mg Tablet. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.

In case of any issues, contact us

Email ID: [email protected]
Phone Number: 0124-4166666
Address: 5th Floor Tower - B of the Presidency Building, 46/4 Mehrauli Gurgaon Road, Sector 14, Gurugram, Haryana-122001, India

1,554 people viewed this recently

₹29704₹30084Get 1% OFF

₹28912+ free shipping with Care Plan Logo

Inclusive of all taxes

Get this discount by applying coupon 1MGALL on the cart. Max. coupon discount is ₹380. T&C apply.

14.0 tablets in 1 strip

Add to cart

Variants (2)

Not returnable Read policy

We provide you with authentic, trustworthy and relevant information

Have issue with the content?

Jakavi 5mg Tablet

Product introduction